Vanguard Group’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

Vanguard Group’s Portfolio FUSN Stock Details FUSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-33,036	Closed	-$704K	–	4467
2024 Q1	$704K	Buy	+33,036	New	+$395K	﹤0.01%	3919
2021 Q2	–	Sell	-36,394	Closed	-$390K	–	4455
2021 Q1	$390K	Buy	36,394 +806	+2%	+$9.42K	﹤0.01%	4169
2020 Q4	$418K	Buy	+35,588	New	+$447K	﹤0.01%	3992

Vanguard Group's FUSN Position: Q2 2024 in Review

Vanguard Group sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q2 2024, closing a stake of 33,036 shares — an estimated $704K sold.

Vanguard Group first reported a position in FUSN in Q4 2020 and held it in 3 quarters. The position peaked at $704K in Q1 2024. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.

Vanguard Group reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q2 2024 after selling out during the quarter.
Vanguard Group sold 33,036 Fusion Pharmaceuticals Inc. Common Shares shares in Q2 2024, an estimated $704K.
Vanguard Group first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q4 2020 and held it in 3 quarters.
Vanguard Group's Fusion Pharmaceuticals Inc. Common Shares position peaked at $704K in Q1 2024.
0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2024.

Based on Vanguard Group's 13F filing for Q2 2024, filed 13 Aug 2024.